Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function

被引:17
|
作者
Tremblay, Jacqueline M. [1 ]
Vazquez-Cintron, Edwin [2 ]
Lam, Kwok-Ho [3 ]
Mukherjee, Jean [1 ]
Bedenice, Daniela [4 ]
Ondeck, Celinia A. [2 ]
Conroy, Matthieu T. [2 ]
Bodt, Skylar M. L. [2 ]
Winner, Brittany M. [2 ]
Webb, Robert P. [5 ]
Ichtchenko, Konstantin [6 ]
Jin, Rongsheng [3 ]
McNutt, Patrick M. [2 ]
Shoemaker, Charles B. [1 ]
机构
[1] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA
[2] US Army, Med Res Inst Chem Def, Aberdeen Proving Ground, MD 21010 USA
[3] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA
[4] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA
[5] US Army, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA
[6] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA
关键词
botulinum neurotoxin; botulism; toxin; antitoxin; single-domain antibody; VHH; neutralization; protease; SINGLE; BINDING; NANOBODIES; AGENTS; CHALLENGE; PROTECTS; DOMAINS; TOXINS; MICE; PH;
D O I
10.3390/toxins12100611
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Botulinum neurotoxin (BoNT) serotype E is one of three serotypes that cause the preponderance of human botulism cases and is a Tier 1 Select Agent. BoNT/E is unusual among BoNT serotypes for its rapid onset and short duration of intoxication. Here we report two large panels of unique, unrelated camelid single-domain antibodies (VHHs) that were selected for their ability to bind to BoNT/E holotoxin and/or to the BoNT/E light chain protease domain (LC/E). The 19 VHHs which bind to BoNT/E were characterized for their subunit specificity and 8 VHHs displayed the ability to neutralize BoNT/E intoxication of neurons. Heterodimer antitoxins consisting of two BoNT/E-neutralizing VHHs, including one heterodimer designed using structural information for simultaneous binding, were shown to protect mice against co-administered toxin challenges of up to 500 MIPLD50. The 22 unique VHHs which bind to LC/E were characterized for their binding properties and 9 displayed the ability to inhibit LC/E protease activity. Surprisingly, VHHs selected on plastic-coated LC/E were virtually unable to recognize soluble or captured LC/E while VHHs selected on captured LC/E were poorly able to recognize LC/E coated to a plastic surface. This panel of anti-LC/E VHHs offer insight into BoNT/E function, and some may have value as components of therapeutic antidotes that reverse paralysis following BoNT/E exposures.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Discovery and optimization of small molecule inhibitors for the botulinum neurotoxin type E protease
    Burtea, Alexander
    Fawaz, Allia A.
    Salzameda, Nicholas T.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [32] Camelid-derived heavy-chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris
    Baghban, Roghayyeh
    Gargari, Seyed Latif Mousavi
    Rajabibazl, Masoumeh
    Nazarian, Shahram
    Bakherad, Hamid
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2016, 63 (02) : 200 - 205
  • [33] A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes
    Garcia-Rodriguez, Consuelo
    Razai, Ali
    Geren, Isin N.
    Lou, Jianlong
    Conrad, Fraser
    Wen, Wei-Hua
    Farr-Jones, Shauna
    Smith, Theresa J.
    Brown, Jennifer L.
    Skerry, Janet C.
    Smith, Leonard A.
    Marks, James D.
    TOXINS, 2018, 10 (03)
  • [34] Development and selection of candidate monoclonal antibodies for the detection of Clostridium botulinum neurotoxin serotype B light chain
    Trinh, Toan Van
    Nguyen, Doai Van
    Hoang, Hieu Dang
    Pham, Hung Viet
    Vu, Duong Ngoc
    Le, Phan Van
    Le, Diep Ngoc
    Vo, Cuong Viet
    Le, Lan Anh Thi
    PROTEIN EXPRESSION AND PURIFICATION, 2025, 228
  • [35] Production of a Neutralizing Mouse-Human Chimeric Antibody against Botulinum Neurotoxin Serotype E
    Mukamoto, Masafumi
    Maeda, Hiroaki
    Kohda, Tomoko
    Nozaki, Chikateru
    Takahashi, Motohide
    Kozaki, Shunji
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (01) : 46 - 50
  • [36] Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E
    Shi, Dan-Yang
    Liu, Fu-Jia
    Mao, Yun-Yun
    Cui, Rong-Tian
    Lu, Jian-Sheng
    Yu, Yun-Zhou
    Dong, Xiao-Jie
    Yang, Zhi-Xin
    Sun, Zhi-Wei
    Pang, Xiao-Bin
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (01) : 100 - 108
  • [37] Codon-optimized HC gene of Clostridium botulinum neurotoxin serotype E is an effective botulism DNA Codon-optimized HC gene of Clostridium botulinum neurotoxin serotype E is an effective botulism DNA vaccine candidate
    Young, Cho Sun
    Young, Lee Bo
    Yang, Jai Myung
    Shin, Sungho
    HUMAN GENE THERAPY, 2010, 21 (10) : 1443 - 1443
  • [38] Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases
    Tremblay, Jacqueline M.
    Kuo, Chueh-Ling
    Abeijon, Claudia
    Sepulveda, Jorge
    Oyler, George
    Hu, Xuebo
    Jin, Moonsoo M.
    Shoemaker, Charles B.
    TOXICON, 2010, 56 (06) : 990 - 998
  • [39] Design and evaluation of mRNA encoding recombinant neutralizing antibodies for botulinum neurotoxin type B intoxication prophylaxis
    Qiaerxie, Gulisaina
    Jiang, Yujia
    Li, Gege
    Yang, Zhixin
    Long, Feng
    Yu, Yunzhou
    Lu, Jian Sheng
    Du, Peng
    Cui, Yong
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [40] Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E
    Li, Zhen
    Lu, Jiansheng
    Tan, Xiao
    Wang, Rong
    Xu, Qing
    Yu, Yunzhou
    Yang, Zhixin
    TOXINS, 2022, 14 (02)